Argonautica Private Wealth Management’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.2M Hold
4,916
0.36% 61
2025
Q4
$1.02M Hold
4,916
0.3% 64
2025
Q3
$912K Sell
4,916
-200
-4% -$34.3K 0.27% 72
2025
Q2
$781K Sell
5,116
-325
-6% -$50K 0.25% 82
2025
Q1
$902K Sell
5,441
-165
-3% -$25.8K 0.31% 73
2024
Q4
$811K Hold
5,606
0.26% 77
2024
Q3
$909K Hold
5,606
0.3% 68
2024
Q2
$819K Hold
5,606
0.28% 75
2024
Q1
$887K Sell
5,606
-8,859
-61% -$1.41M 0.32% 71
2023
Q4
$2.27M Buy
14,465
+163
+1% +$25K 0.93% 31
2023
Q3
$2.23M Buy
14,302
+154
+1% +$25.4K 1% 31
2023
Q2
$2.34M Buy
14,148
+248
+2% +$40K 1.05% 27
2023
Q1
$2.15M Sell
13,900
-2,199
-14% -$355K 1.09% 30
2022
Q4
$2.84M Buy
+16,099
New +$2.78M 1.46% 25

Other funds holding JNJ

Argonautica Private Wealth Management's JNJ Position: Q1 2026 in Review

Argonautica Private Wealth Management held its Johnson & Johnson (JNJ) position steady in Q1 2026 at 4,916 shares worth $1.2M. The position accounts for 0.36% of the portfolio, ranked #61.

Argonautica Private Wealth Management first reported a position in JNJ in Q4 2022 and has held it in 14 quarters since. The position peaked at $2.84M in Q4 2022. 4,615 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • Argonautica Private Wealth Management held 4,916 shares of Johnson & Johnson worth $1.2M as of Q1 2026.
  • Argonautica Private Wealth Management left its Johnson & Johnson share count unchanged in Q1 2026.
  • Johnson & Johnson made up 0.36% of Argonautica Private Wealth Management's portfolio in Q1 2026, its #61 holding.
  • Argonautica Private Wealth Management first reported a position in Johnson & Johnson in Q4 2022 and has held it in 14 quarters since.
  • Argonautica Private Wealth Management's Johnson & Johnson position peaked at $2.84M in Q4 2022.
  • 4,615 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on Argonautica Private Wealth Management's 13F filing for Q1 2026, filed 28 Apr 2026.